|
⚲
|
| Keyboard |
| Lebuhn Robert
✚
|
|
|---|---|
| CIK # | 0001007931 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001007931] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lebuhn Robert | |
| Enzon Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Enzon Pharmaceuticals Inc ENZN
Common Stock
|
2013-09-19 | Sell | 21,119 | $1.69 | 35,691 |
|
Enzon Pharmaceuticals Inc ENZN
Common Stock
|
2013-09-17 | Sell | 34,807 | $1.74 | 60,564 |
|
Enzon Pharmaceuticals Inc ENZN
Stock Option (Right to Buy) · derivative
|
2013-01-02 | Grant | 20,129 | $0.00 | |
|
Enzon Pharmaceuticals Inc ENZN
Common Stock
|
2012-08-14 | Sell | 5,820 | $6.58 | 38,296 |
|
Enzon Pharmaceuticals Inc ENZN
Common Stock
|
2012-08-10 | Sell | 1,933 | $6.58 | 12,719 |
|
Enzon Pharmaceuticals Inc ENZN
Common Stock
|
2012-07-02 | Grant | 10,669 | $0.00 | |
|
Enzon Pharmaceuticals Inc ENZN
Stock Option (Right to Buy) · derivative
|
2012-01-03 | Grant | 10,994 | $0.00 |